Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

VK2809 found that those on the medicine saw statistically significant reductions in liver fat, meeting the primary endpoint.

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...

Consuming 2 to 3 cups of green tea daily may facilitate fat metabolism and diminish inflammation within the liver, thereby assisting in the treatment of fatty liver disease ... Curry leaves possess ...

Stress hormones, not impaired insulin signaling, may underlie obesity-related diabetes, according to Rutgers research.

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...

Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

Research shows young people are increasingly open to noninvasive aesthetic treatments and plastic surgery. One writer ...

A new study led by researchers at The University of Texas at Austin and Harvard Medical School reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during ...

Doctors say GLP-1s are not approved as a prevention method for menopause weight gain. Here's how to manage the weight changes ...

A new study reveals surprising findings about how babies exposed to gestational diabetes mellitus (GDM) grow during their ...